# FDA Inspection 1284446 - Baxter Healthcare Corporation - September 29, 2025

Source: https://www.keypedia.com/records/fda_inspections/baxter-healthcare-corporation/bca90a34-d045-41e0-8c4a-1c7913aa79df
Source feed: FDA_Inspections

> FDA Inspection 1284446 for Baxter Healthcare Corporation on September 29, 2025. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1284446
- Company Name: Baxter Healthcare Corporation
- Inspection Date: 2025-09-29
- Classification: Official Action Indicated (OAI)
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Office Name: New Orleans District Office

## Related Documents

- [FDA Inspection 1210861 - 2023-07-14](https://www.keypedia.com/records/fda_inspections/baxter-healthcare-corporation/0819901e-5b8e-41db-aa03-e1aa98da7dd8)
- [FDA Inspection 1210861 - 2023-07-14](https://www.keypedia.com/records/fda_inspections/baxter-healthcare-corporation/fb848831-3d57-48a4-b9b6-9d203587434a)
- [FDA Inspection 1072203 - 2018-11-20](https://www.keypedia.com/records/fda_inspections/baxter-healthcare-corporation/6be8d884-f3b8-464d-ac77-0104733ded2a)
- [FDA Inspection 1072203 - 2018-11-20](https://www.keypedia.com/records/fda_inspections/baxter-healthcare-corporation/c9feb4e5-d47a-4f96-b8b4-93ff0d859b9d)
- [FDA Inspection 1010362 - 2017-03-29](https://www.keypedia.com/records/fda_inspections/baxter-healthcare-corporation/0d74091b-6ddc-460a-b054-fe45cc5527e7)

Company: https://www.keypedia.com/companies/baxter-healthcare-corporation/738590ab-c241-4de1-aaec-722e154bfc45

Office: https://www.keypedia.com/offices/new-orleans-district-office/95352142-b992-4e06-849d-d7483c0959ea